sufentanil has been researched along with etorphine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kreeger, TJ; Seal, US | 1 |
| Day, AR; Freer, RJ; Liao, CS | 1 |
| Grevel, J; Richards, ML; Rosenbaum, JS; Sadée, W | 1 |
| Holford, NH; Rosenbaum, JS; Sadée, W | 1 |
| Aman, RA; Holford, NH; Richards, ML; Rosenbaum, JS; Sadée, W | 1 |
| Lazar, DF; Medzihradsky, F | 1 |
| Freye, E; Levy, JV | 1 |
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
9 other study(ies) available for sufentanil and etorphine
| Article | Year |
|---|---|
Immobilization of gray wolves (Canis lupus) with sufentanil citrate.
Topics: Anesthetics; Animals; Arousal; Carnivora; Etorphine; Female; Fentanyl; Immobilization; Male; Naloxone; Sufentanil; Xylazine; Yohimbine | 1990 |
Evidence for a single opioid receptor type on the field stimulated rat vas deferens.
Topics: Animals; Benzimidazoles; beta-Endorphin; Dose-Response Relationship, Drug; Electric Stimulation; Endorphins; Enkephalins; Etorphine; Fentanyl; Male; Morphine; Oxymorphone; Rats; Rats, Inbred Strains; Receptors, Opioid; Sufentanil; Vas Deferens | 1981 |
In vivo characterization of four types of opioid binding sites in rat brain.
Topics: Analgesics, Opioid; Animals; Brain; Buprenorphine; Diprenorphine; Etorphine; Fentanyl; Male; Naloxone; Rats; Rats, Inbred Strains; Receptors, Opioid; Sufentanil; Tritium | 1983 |
Opiate receptor binding-effect relationship: sufentanil and etorphine produce analgesia at the mu-site with low fractional receptor occupancy.
Topics: Animals; Brain; Diprenorphine; Drug Interactions; Etorphine; Fentanyl; Morphinans; Naloxone; Pain; Rats; Receptors, Opioid; Sufentanil | 1984 |
Discrimination of three types of opioid binding sites in rat brain in vivo.
Topics: Animals; Binding, Competitive; Brain; Diprenorphine; Etorphine; Fentanyl; Male; Naloxone; Rats; Receptors, Opioid; Sufentanil | 1984 |
Altered transition between agonist- and antagonist-favoring states of mu-opioid receptor in brain membranes with modified microviscosity.
Topics: Animals; Brain; Cholesterol Esters; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Etorphine; Male; Membrane Fluidity; Membranes; Naltrexone; Oleic Acid; Oleic Acids; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Sodium Chloride; Sufentanil; Viscosity | 1993 |
No hyperalgesia following opioid withdrawal after the oripavine derivative etorphine compared to remifentanil and sufentanil.
Topics: Afferent Pathways; Analgesics, Opioid; Animals; Blood Pressure; Bradycardia; Dogs; Dose-Response Relationship, Drug; Etorphine; Evoked Potentials, Somatosensory; Heart Rate; Hyperalgesia; Hypotension; Naloxone; Narcotic Antagonists; Piperidines; Remifentanil; Substance Withdrawal Syndrome; Sufentanil | 2010 |
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |